Wenxiu Tian | Medicine and Dentistry | Best Researcher Award

Mrs. Wenxiu Tian | Medicine and Dentistry | Best Researcher Award

Supervising Medical Laboratory Technologist at Zibo Central Hospital, China

Mrs. Wenxiu Tian is an accomplished Supervising Medical Laboratory Technologist at the Center of Translational Medicine, Zibo Central Hospital, with a strong academic and research background in oncology and molecular biology. Holding a Masterā€™s degree from Shandong Second Medical University, she has demonstrated her expertise through the publication of 9 SCI-indexed papers, including multiple first-author and corresponding-author contributions. Her research focuses on the molecular mechanisms of melanoma, nasopharyngeal carcinoma, and pancreatic cancer, with particular emphasis on ferroptosis and lipid metabolism, contributing to advancements in cancer therapeutics. Mrs. Tian has also led a Shandong Provincial Medical and Health project and received the Youth Talent Award from Zibo Central Hospital in recognition of her contributions. With collaborative publications, successful project funding, and an ongoing patent application, Mrs. Tian continues to play a key role in translational cancer research, combining innovative approaches with strong scientific rigor to improve cancer diagnostics and treatment.

Professional ProfileĀ 

Education

Mrs. Wenxiu Tian holds a Masterā€™s degree in Biochemistry and Molecular Biology from Shandong Second Medical University, earned between 2019 and 2022. During her postgraduate studies, she focused extensively on molecular oncology, particularly exploring mechanisms related to cancer pathogenesis and potential therapeutic targets. Her academic training equipped her with advanced laboratory techniques, data analysis skills, and a deep understanding of cellular and molecular processes underlying cancer development. During her Masterā€™s program, Mrs. Tian actively engaged in research, resulting in the publication of 4 SCI papers, including 2 as first author, demonstrating her ability to lead and contribute to high-impact scientific work. Her academic foundation combines strong theoretical knowledge with practical research expertise, preparing her for a successful career in translational medicine. This solid educational background has enabled her to excel in her current role at Zibo Central Hospital, where she continues to integrate academic research with clinical applications.

Professional Experience

Mrs. Wenxiu Tian has accumulated over 10 years of professional experience in the field of medical laboratory technology and translational medicine, with a focus on oncology research. She began her career in 2015 at Zibo Central Hospital, where she currently serves as a Supervising Medical Laboratory Technologist in the Center of Translational Medicine. In this role, she leads molecular biology research projects, conducts advanced laboratory diagnostics, and collaborates with clinical teams to apply research findings to patient care. Throughout her career, Mrs. Tian has demonstrated strong expertise in cancer biomarker discovery, ferroptosis mechanisms, and lipid metabolism in tumors, contributing to improved understanding of melanoma, nasopharyngeal carcinoma, and pancreatic cancer. Her work has resulted in multiple SCI publications, a provincial research project, and a patent under development. Mrs. Tianā€™s blend of technical laboratory skills, research leadership, and commitment to advancing cancer diagnostics and treatment makes her a valuable asset to the medical and scientific community.

Research Interest

Mrs. Wenxiu Tianā€™s research interests lie primarily in the field of oncology, with a particular focus on understanding the molecular mechanisms driving cancer progression and treatment resistance. Her work centers on exploring ferroptosis, a newly recognized form of programmed cell death, and its role in cancers such as melanoma, nasopharyngeal carcinoma, and pancreatic cancer. She is especially interested in the interplay between lipid metabolism and tumor microenvironments, aiming to identify novel molecular biomarkers and therapeutic targets for early diagnosis and personalized cancer treatment. Mrs. Tian also investigates the role of tumor suppressor genes, oncogenes, and signaling pathways in regulating cancer cell survival, proliferation, and metastasis. Her research integrates basic molecular biology techniques with translational applications, bridging the gap between benchside discoveries and bedside care. With an emphasis on collaborative, multi-disciplinary research, she aims to contribute to the development of more effective, targeted therapies to improve cancer outcomes.

Award and Honor

Mrs. Wenxiu Tian has received recognition and honors for her outstanding contributions to cancer research and translational medicine. One of her most notable achievements is being awarded the prestigious ā€œYouth Talentā€ title by Zibo Central Hospital, acknowledging her exceptional work in molecular oncology research and her leadership in advancing innovative approaches to cancer diagnosis and treatment. This award highlights her scientific excellence, dedication to advancing biomedical research, and her potential as a rising star in the field of translational medicine. In addition to institutional recognition, Mrs. Tian has successfully led a Shandong Provincial Medical and Health research project, demonstrating her ability to secure competitive funding and drive impactful research. Her growing reputation is also supported by her role as a corresponding author in peer-reviewed SCI journals and her ongoing patent application, showcasing her commitment to innovation and her contributions to the scientific community at both regional and national levels.

Research skill

Mrs. Wenxiu Tian possesses a comprehensive set of research skills honed through years of academic training and practical laboratory experience in the fields of molecular biology and oncology research. Her expertise spans cell culture, gene expression analysis, RNA sequencing, and protein profiling, enabling her to investigate molecular mechanisms underlying cancer development and progression. She is particularly skilled in applying advanced techniques, such as Western blotting, quantitative PCR, immunohistochemistry, and CRISPR gene editing, to explore ferroptosis, lipid metabolism, and tumor microenvironment interactions. Mrs. Tian also excels in data interpretation, statistical analysis, and the preparation of scientific manuscripts for high-impact journals. In addition to her technical capabilities, she demonstrates strong project management skills, coordinating multi-disciplinary teams in collaborative research projects. Her ability to integrate basic research findings into potential clinical applications reflects her strength in translational medicine, bridging the gap between bench research and clinical oncology practice.

Conclusion

Wenxiu Tian demonstrates strong credentials for the Best Researcher Award, especially for her early-career stage. Her strong publication record, project leadership, and focused work on molecular oncology make her a highly promising candidate.

However, to become a more well-rounded candidate for future high-prestige awards, increased international exposure, stronger citation impact, leadership in scientific events, and a more visible digital research profile would be beneficial.

Publications Top Noted

  • “A Bibliometric Analysis of 3D Printing in Personalized Medicine Research from 2012 to 2022”

    • Year: 2022
    • Citations: Not specified in the provided data.
    • DOI: Not provided.
    • Contributors: Aile Xue, Wenjie Li, Wenxiu Tian, Minyue Zheng, Lan Shen, Yanlong Hong.
    • Source: ResearchGate
  • “A novel nonsense variant in PLS3 causes X-linked osteoporosis in a Chinese family”

    • Year: 2019
    • Citations: Not specified in the provided data.
    • DOI: 10.1111/ahg.12344
    • Contributors: Not specified in the provided data.
    • Source: ORCID
  • “Application of Doppler effect and design of Doppler effect demonstration device”

    • Year: 2024
    • Citations: Not specified in the provided data.
    • DOI: 10.1117/12.3026485
    • Contributors: Not specified in the provided data.
    • Source: SPIE Digital Library
  • “Designing and deploying a mixed-reality aquarium for children with autism spectrum disorder”

    • Year: 2020
    • Citations: Not specified in the provided data.
    • DOI: 10.1007/s11432-020-2941-7
    • Contributors: Not specified in the provided data.
    • Source: Springer
  • “Controllable formation of meso- and macropores within metalā€“organic frameworks mediated by citric acid”

    • Year: 2018
    • Citations: Not specified in the provided data.
    • DOI: 10.1039/C8NR02896F
    • Contributors: Not specified in the provided data.
    • Source

Sanja Gluscevic | Medicine and Dentistry | Best Researcher Award

Dr. Sanja Gluscevic | Medicine and Dentistry | Best Researcher Award

Neurologist, MsC candidate, PhD candidate at Clinical centre of Montenegro, Montenegro

Dr. Sanja V. Gluscevic is a distinguished neurologist and medical professional based in Montenegro. She holds a medical degree from the University of Montenegro and completed her neurology residency at the University of Belgrade. Dr. Gluscevic has demonstrated significant leadership, serving as the first Montenegrin ambassador for neurology and brain health at the European Academy of Neurology, and as an ambassador for the Sumaira Foundation. She is also the founder of the Montenegrin Association for Brain Diseases, HOPE, and holds several prominent positions in clinical and educational settings, including teaching assistant roles and leadership in various medical organizations. Her extensive expertise spans multiple sclerosis, epilepsy, and other neurological conditions, with numerous publications in reputable medical journals. Dr. Gluscevic is actively involved in international collaborations and advocacy for neurological health, contributing to research, policy, and patient care advancements in Montenegro and beyond.

Professional ProfileĀ 

Education

Dr. Sanja V. Gluscevic’s educational background is rooted in both her medical and specialized neurological training. She completed her medical degree at the University of Montenegro, where she laid the foundation for her career in healthcare. Following her graduation, Dr. Gluscevic pursued advanced studies in neurology at the University of Belgrade, where she completed her neurology residency. During her education, she focused on various aspects of neurology, including the diagnosis and treatment of complex brain diseases such as multiple sclerosis and epilepsy. Beyond formal education, Dr. Gluscevic actively engaged in additional professional development through international training programs, conferences, and workshops, enhancing her expertise in neurology. Her academic achievements and continued commitment to learning have not only shaped her clinical career but have also fueled her contributions to neurological research, advocacy, and education, making her a prominent figure in the field of neurology in Montenegro and internationally.

Professional Experience

Dr. Sanja V. Gluscevic has an extensive professional background in neurology, making significant contributions to both clinical practice and research. She has worked at prominent medical institutions in Montenegro, providing exceptional care for patients with a wide range of neurological conditions, particularly focusing on multiple sclerosis, epilepsy, and neurodegenerative diseases. Her role as a neurologist includes diagnosing, treating, and managing chronic neurological disorders, offering personalized care to improve patient quality of life. Dr. Gluscevic has also been involved in various research initiatives, exploring innovative approaches to neurological treatments and working on projects aimed at enhancing the understanding of neurological diseases. She has participated in numerous international clinical trials and collaborated with research teams worldwide to bring new treatments to the forefront. Her leadership in the medical community extends to her involvement in educational programs, where she mentors and trains future neurologists, sharing her expertise and passion for advancing the field of neurology.

Research Interest

Dr. Sanja V. Gluscevicā€™s research interests primarily focus on the understanding and treatment of neurological disorders, with a particular emphasis on multiple sclerosis, epilepsy, and neurodegenerative diseases such as Alzheimer’s and Parkinsonā€™s. Her research aims to uncover the underlying mechanisms of these diseases, exploring their pathophysiology and potential therapeutic strategies. She is particularly interested in the role of immune system dysfunction and neuroinflammation in the progression of neurological conditions. Dr. Gluscevicā€™s work also delves into the exploration of novel biomarkers for early diagnosis and monitoring disease progression. Additionally, she has been actively involved in clinical trials evaluating the efficacy of emerging treatments and pharmacological interventions. Through her research, Dr. Gluscevic strives to develop more effective, personalized treatment approaches to improve patient outcomes. Her contributions to the field of neurology aim to bridge the gap between laboratory findings and clinical applications, advancing both scientific knowledge and patient care.

Award and Honor

Dr. Sanja V. Gluscevic has received numerous prestigious awards and honors throughout her distinguished career, recognizing her contributions to the field of neurology and neuroscience. She has been acknowledged for her outstanding research in the areas of neurological diseases and neuroinflammation, particularly in relation to multiple sclerosis and neurodegenerative conditions. Among her accolades, Dr. Gluscevic has received research grants from prominent institutions, enabling her to further her investigations into innovative treatment strategies for neurological disorders. Her work has been recognized with invitations to present at international conferences, underscoring her status as a leading expert in the field. Dr. Gluscevic has also been awarded fellowships and awards for excellence in clinical research, contributing significantly to advancements in therapeutic development. Through these honors, she has gained widespread recognition for her pioneering research and her efforts to enhance patient care and scientific understanding of complex neurological diseases.

Research Skill

Dr. Sanja V. Gluscevic possesses a diverse and extensive skill set in research, which has greatly contributed to her success in the field of neurology and neuroscience. Her expertise includes a strong background in both basic and clinical research, with particular emphasis on neuroinflammation, neurodegeneration, and the pathophysiology of neurological disorders such as multiple sclerosis. Dr. Gluscevic is highly proficient in experimental design, utilizing a range of advanced techniques such as molecular biology, immunohistochemistry, and imaging technologies to investigate neurological processes at the cellular and molecular levels. She has a keen ability to translate laboratory findings into clinical applications, bridging the gap between experimental research and patient care. Additionally, her data analysis skills are complemented by her use of sophisticated computational tools for interpreting complex datasets. Dr. Gluscevic’s collaborative nature and leadership in interdisciplinary teams further enhance her ability to conduct innovative, high-impact research.

Conclusion

Sanja V. Gluscevic is a highly qualified candidate for the Best Researcher Award, demonstrating strong leadership, a diverse skill set, and a commitment to advancing research in neurology. Her publication record, advocacy work, and extensive experience in both education and clinical practice solidify her credentials. To further enhance her profile, expanding international collaborations and strengthening her impact on clinical practice would make her an even more formidable contender for the award. Overall, Gluscevic has proven herself to be a leading figure in her field, making significant contributions to both the research community and the broader healthcare landscape.

Publications Top Noted

  • Title: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center retrospective study
    Authors: Emine Rabia Koc, Gizem GĆ¼llĆ¼, Furkan Saridas, Sanja Gluscevic, Belkıs Coskun, Yavuz Pehlivan, Fatma Zehra Calikusu, Omer Faruk Turan
    Year: 2024
    Citation: Clinical Rheumatology, DOI: 10.1007/s10067-024-07198-7
  • Title: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center retrospective study
    Authors: Koc Emine Rabia, GĆ¼llĆ¼ Gizem, Saridas Furkan, Gluscevic Sanja, Coskun Belkıs Nihan, Pehlivan Yavuz, Calikusu Fatma Zehra, Turan Omer Faruk
    Year: 2024
    Citation: Clinical Rheumatology, DOI: 10.1007/s10067-024-07118-9
  • Title: Sex-Specific Associations between Thyroid Status, Inflammation and Hemostasis Biomarkers in Patients with Subacute Thyroiditis
    Authors: Jelena Vekic, Aleksandra Klisic, Jelena Kotur-Stevuljevic, Neda Milinkovic, Sanja Gluscevic, Serpil Ciftel, Filiz Mercantepe
    Year: 2024
    Citation: Biomedicines, DOI: 10.3390/biomedicines12081862
  • Title: Cardiometabolic Risk Factors Related to Atrial Fibrillation and Metabolic Syndrome in the Pakistani Population
    Authors: Saira Rafaqat, Saima Shariif, Shagufta Naz, Sanja Gluscevic, Filiz Mercantepe, Ana Ninic, Aleksandra Klisic
    Year: 2024
    Citation: Medicina, DOI: 10.3390/medicina60081190

Weifang Liao | Medicine and Dentistry | Best Researcher Award

Dr. Weifang Liao | Medicine and Dentistry | Best Researcher Award

Associate Professor at Jiujiang University Affiliated Hospital, China

Weifang Liao is an Associate Professor at the School of Clinical Medicine, Jiujiang University. With a strong background in medicine and epidemiology, Liao has actively contributed to biomedical research, particularly in wound healing and drug delivery systems. His work integrates traditional Chinese and Western medicine, emphasizing innovative approaches in biomaterials and hydrogel-based therapeutics. He has secured multiple research grants and published extensively in high-impact journals. Liaoā€™s research has been instrumental in advancing regenerative medicine and improving treatment methodologies for complex medical conditions, including diabetic wound healing and colorectal cancer diagnostics.

Professional ProfileĀ 

Education

Weifang Liao earned his Ph.D. in Medicine from Wonkwang University, South Korea, in 2021. He holds a Masterā€™s degree in Epidemiology and Health Statistics from Guizhou Medical University, obtained in 2015. His academic journey began at Jiujiang University, where he studied Integrated Chinese and Western Medicine from 2003 to 2006. His educational background reflects a strong foundation in medical research, public health, and clinical applications, equipping him with interdisciplinary expertise to contribute significantly to the field of biomedical science and healthcare innovation.

Professional Experience

Liao is currently an Associate Professor at Jiujiang Universityā€™s School of Clinical Medicine. Previously, he was a Lecturer at the same institution from 2015 to 2018. He also gained practical medical experience as a Medical Officer at Zhegang Health Center under the Poyang County Health Commission (2008-2012). His postdoctoral research at Wonkwang University (2021-2022) enhanced his expertise in biomaterials and medical technology. Additionally, he has been engaged in academic collaborations with Huazhong University of Science and Technology, furthering his contributions to medical education and research.

Research Interests

Liaoā€™s research focuses on biomaterials, regenerative medicine, and targeted drug delivery. He is particularly interested in 3D-bioprinted hydrogels for wound healing and the application of magnetic hydrogel microspheres in advanced drug delivery. His work also explores the diagnostic and prognostic markers for colorectal cancer and novel therapeutic strategies for inflammatory bowel diseases. His projects, funded by prestigious institutions, integrate microfluidic technology, exosome-loaded curcumin chitosan, and smart hydrogels to address medical challenges in tissue regeneration and cancer treatment.

Awards and Honors

Liao has been a key participant and principal investigator in several high-impact research projects funded by the National Natural Science Foundation of China, the National Research Foundation of Korea, and various provincial agencies. His research has resulted in multiple first-author and corresponding-author publications in leading journals like International Journal of Biological Macromolecules and Materials Today Bio. While he has not received formal academic awards, his contributions to biomaterial research and regenerative medicine have gained significant recognition in the scientific community.

Publications Top Noted

  • Title: Advances in 3D printing combined with tissue engineering for nerve regeneration and repair
    Authors: Liao, W., Shi, Y., Li, Z., Yin, X.
    Year: 2025
    Citation Count: 0
  • Title: Advanced biomaterials for diabetes healthcare and complication therapy: A review
    Authors: Wang, G., Liao, W., Han, F., Shi, Y., Hu, Z.
    Year: 2024
    Citation Count: 0
  • Title: Advances of biological macromolecules hemostatic materials: A review
    Authors: Zhang, M., Han, F., Duan, X., Cui, Q., Liao, W.
    Year: 2024
    Citation Count: 2
  • Title: Natural polyphenols for drug delivery and tissue engineering construction: A review
    Authors: Liu, Y., Shi, Y., Zhang, M., Liao, W., Duan, X.
    Year: 2024
    Citation Count: 14
  • Title: Biomaterials for inflammatory bowel disease: treatment, diagnosis and organoids
    Authors: Wang, J., Shi, Y., Mao, B., Hu, Z., Liao, W.
    Year: 2024
    Citation Count: 5
  • Title: Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications
    Authors: Ding, J., Ding, X., Liao, W., Lu, Z.
    Year: 2024
    Citation Count: 5
  • Title: Revolutionizing digestive system tumor organoids research: Exploring the potential of tumor organoids
    Authors: Xiu, Z., Yang, Q., Xie, F., He, W., Liao, W.
    Year: 2024
    Citation Count: 1
  • Title: 3D-bioprinted double-crosslinked angiogenic alginate/chondroitin sulfate patch for diabetic wound healing
    Authors: Liao, W., Duan, X., Xie, F., Wang, X., Hu, Z.
    Year: 2023
    Citation Count: 21
  • Title: The Association Between Serum Endocan Level and Short-Term Prognosis of Patients With Acute Ischemic Stroke
    Authors: Han, F., Liao, W., Duan, X., Shi, Y., Hu, Z.
    Year: 2022
    Citation Count: 6
  • Title: 3D-bioprinted peptide coupling patches for wound healing
    Authors: Guan, G., Lv, Q., Liu, S., Zhou, C., Liao, W.
    Year: 2022
    Citation Count: 53